The evidence for cognitive behavioural therapy in any condition, population or context: a meta-review of systematic reviews and panoramic meta-analysis

荟萃分析 心理信息 奇纳 梅德林 背景(考古学) 人口 医学 系统回顾 随机对照试验 置信区间 临床心理学 生活质量(医疗保健) 心理健康 心理学 精神科 心理干预 环境卫生 内科学 古生物学 政治学 法学 生物 护理部
作者
Beth Fordham,Thavapriya Sugavanam,Katherine Edwards,Paul Stallard,Robert Howard,Roshan das Nair,Bethan Copsey,Hopin Lee,Jeremy Howick,Karla Hemming,Sarah E Lamb
出处
期刊:Psychological Medicine [Cambridge University Press]
卷期号:51 (1): 21-29 被引量:79
标识
DOI:10.1017/s0033291720005292
摘要

Abstract The majority of psychological treatment research is dedicated to investigating the effectiveness of cognitive behavioural therapy (CBT) across different conditions, population and contexts. We aimed to summarise the current systematic review evidence and evaluate the consistency of CBT's effect across different conditions. We included reviews of CBT randomised controlled trials in any: population, condition, format, context, with any type of comparator and published in English. We searched DARE, Cochrane, MEDLINE, EMBASE, PsycINFO, CINAHL, CDAS, and OpenGrey between 1992 and January 2019. Reviews were quality assessed, their data extracted and summarised. The effects upon health-related quality of life (HRQoL) were pooled, within-condition groups. If the across-condition heterogeneity was I 2 < 75%, we pooled effects using a random-effect panoramic meta-analysis. We summarised 494 reviews (221 128 participants), representing 14/20 physical and 13/20 mental conditions (World Health Organisation's International Classification of Diseases). Most reviews were lower-quality (351/494), investigated face-to-face CBT (397/494), and in adults (378/494). Few reviews included trials conducted in Asia, South America or Africa (45/494). CBT produced a modest benefit across-conditions on HRQoL (standardised mean difference 0.23; 95% confidence intervals 0.14–0.33, I 2 = 32%). The effect's associated prediction interval −0.05 to 0.50 suggested CBT will remain effective in conditions for which we do not currently have available evidence. While there remain some gaps in the completeness of the evidence base, we need to recognise the consistent evidence for the general benefit which CBT offers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
哈哈发布了新的文献求助10
1秒前
彩色皓轩完成签到,获得积分10
2秒前
星空发布了新的文献求助10
4秒前
4秒前
4秒前
5秒前
852应助kyri采纳,获得30
6秒前
香蕉觅云应助纪元龙采纳,获得10
6秒前
7秒前
哈哈完成签到,获得积分20
8秒前
归仔发布了新的文献求助10
9秒前
9秒前
幽默身影发布了新的文献求助30
9秒前
Yi完成签到,获得积分10
10秒前
10秒前
10秒前
Jasper应助yshog采纳,获得10
11秒前
11秒前
宗谷秋发布了新的文献求助10
11秒前
明理的依柔完成签到,获得积分10
12秒前
12秒前
归仔发布了新的文献求助10
12秒前
52cc000完成签到,获得积分20
13秒前
大个应助小药师采纳,获得30
14秒前
pure123发布了新的文献求助10
14秒前
14秒前
15秒前
wz发布了新的文献求助10
15秒前
峨眉峰发布了新的文献求助10
16秒前
cc发布了新的文献求助10
16秒前
奋斗雅香完成签到 ,获得积分10
16秒前
17秒前
脑洞疼应助江户川采纳,获得10
17秒前
tang发布了新的文献求助10
18秒前
18秒前
tuzhifengyin完成签到,获得积分10
20秒前
科研通AI6.2应助wulei采纳,获得10
20秒前
LUOSHEN发布了新的文献求助10
20秒前
goodjust完成签到 ,获得积分10
21秒前
yshog发布了新的文献求助10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6954876
求助须知:如何正确求助?哪些是违规求助? 8638548
关于积分的说明 18319194
捐赠科研通 6399642
什么是DOI,文献DOI怎么找? 3083431
关于科研通互助平台的介绍 2129689
邀请新用户注册赠送积分活动 2060235